5,471 Shares in Henry Schein, Inc. (NASDAQ:HSIC) Purchased by Sanctuary Advisors LLC

Sanctuary Advisors LLC acquired a new position in Henry Schein, Inc. (NASDAQ:HSICFree Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 5,471 shares of the company’s stock, valued at approximately $351,000.

Several other institutional investors also recently bought and sold shares of the company. Empirical Finance LLC boosted its holdings in Henry Schein by 3.5% in the 1st quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock worth $360,000 after buying an additional 160 shares during the last quarter. Covestor Ltd boosted its holdings in Henry Schein by 12.8% in the 1st quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after buying an additional 171 shares during the last quarter. Simplify Asset Management Inc. boosted its holdings in shares of Henry Schein by 5.0% during the 2nd quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock worth $237,000 after purchasing an additional 175 shares during the last quarter. Sequoia Financial Advisors LLC grew its position in shares of Henry Schein by 3.2% in the second quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock valued at $364,000 after purchasing an additional 176 shares in the last quarter. Finally, Studio Investment Management LLC grew its position in shares of Henry Schein by 4.7% in the second quarter. Studio Investment Management LLC now owns 4,502 shares of the company’s stock valued at $289,000 after purchasing an additional 204 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have recently issued reports on the company. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research report on Friday, September 20th. JPMorgan Chase & Co. dropped their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating for the company in a research report on Monday, August 12th. UBS Group dropped their price target on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research report on Wednesday, August 7th. Finally, Piper Sandler reiterated an “overweight” rating and issued a $86.00 price objective on shares of Henry Schein in a research report on Friday, June 21st. One investment analyst has rated the stock with a sell rating, six have given a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Henry Schein has an average rating of “Hold” and an average target price of $77.50.

Get Our Latest Analysis on Henry Schein

Henry Schein Stock Down 0.1 %

NASDAQ:HSIC opened at $71.67 on Friday. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The stock’s fifty day moving average is $70.26 and its two-hundred day moving average is $69.90. Henry Schein, Inc. has a 52 week low of $60.01 and a 52 week high of $82.63. The stock has a market capitalization of $9.18 billion, a price-to-earnings ratio of 24.21, a price-to-earnings-growth ratio of 1.98 and a beta of 0.86.

Henry Schein (NASDAQ:HSICGet Free Report) last released its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping analysts’ consensus estimates of $1.22 by $0.01. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The company had revenue of $3.10 billion for the quarter, compared to analysts’ expectations of $3.27 billion. During the same period in the prior year, the firm earned $1.31 earnings per share. The firm’s revenue was up .0% compared to the same quarter last year. Research analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current year.

Insiders Place Their Bets

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the sale, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.14% of the stock is owned by insiders.

Henry Schein Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Stories

Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSICFree Report).

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.